Sign in
4

Changes in Ownership

Chemomab Therapeutics Ltd. Filed Acc 0001178913-22-001179

Executive VP, CFO & COO bought 1,250 shares at an average $4.04 ($5,045)

From the SEC's structured data for this filing

Trades in this filing

Marvin Donald · Executive VP, CFO & COO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-14 Purchase : show line 1 in the form +250 $4.00 $1,000 250 D
2022-03-14 Purchase : show line 2 in the form +250 $3.98 $995 500 D
2022-03-14 Purchase : show line 3 in the form +250 $3.90 $975 1,000 D
2022-03-14 Purchase : show line 4 in the form +250 $4.10 $1,025 1,250 D
2022-03-14 Purchase : show line 5 in the form +250 $4.20 $1,050 1,500 D
Open-market purchases · 1,250 sh · avg $4.04 · $5,045

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-11-08 Grant or award : show line 6 in the form Option to Purchase American Depositary Shares +196,875 196,875 D
Loading xslF345X03/ownership.xml…